Single Cell Multiomics Market by Type, (Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, and Single Cell Metabolomics), Application (Oncology, Cell Biology, Neurology, and Others), Technique (Single-Cell Isolation & Dispensing and Single-Cell Analysis), and End User, (Academic Institutes, Contract Research Organizations, and Pharmaceutical & Biotech Companies): Global Opportunity Analysis and Industry Forecast, 2021–2030
- ALL4621751
- 287 Pages
- June 2021
- Medical Devices
Single cell multiomics technologies typically measure numerous types of molecules from the same individual cell, allowing more profound biological insight than can be inferred by analyzing each molecular layer from separate cells. Furthermore, single cell multiomics technologies can reveal cellular heterogeneity at multiple molecular layers within a population of cells and reveal how this variation is coupled or uncoupled between the captured omic layers. Furthermore, advances in single-cell isolation and barcoding technologies offer unprecedented opportunities to profile DNA, mRNA, and proteins at a single-cell resolution. Recently, bulk multiomics analyses, such as multidimensional genomic and proteogenomic analyses, have proven beneficial for obtaining a comprehensive understanding of cellular events. Moreover, this benefit has facilitated the development of single-cell multiomics analysis, which allows cell type specific gene regulation to be examined.
The factors that drive the single cell multiomics market growth include technological advancements in single-cell analysis products and rise in number of large-scale genomics studies leveraging single-cell RNA Sequencing (sc-RNA). Moreover, increasing adoption of personalized medicine for screening and diagnostics of genetic disorders and rising disposable income in emerging economies drive the growth of the single cell multiomics market. However, high cost of single-cell analysis, dearth of skilled professionals, and integration of data & limited availability of large online data storage and analysis platforms are expected to restrain the growth of the market. Moreover, increasing funding in research of single cell multiomics is anticipated to provide lucrative growth opportunities for market players.
The global single cell multiomics market is segmented on the basis of type, application, technique, end user, and region. On the basis of type, the market is categorized into single cell genomics, single cell proteomics, single cell transcriptomics, and single cell metabolomics. By application, it is classified into oncology, cell biology, neurology, and others. By technique, it is divided into single-cell isolation & dispensing and single-cell analysis. Furthermore, single-cell isolation is further classified into oncology, cell biology, neurology, and others. Moreover, single-cell analysis is further divided into oncology, cell biology, neurology, and others. By end user, it is segmented into academic institutes, contract research organizations, and pharmaceutical & biotech companies. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the global single cell multiomics market along with the current trends and future estimations to elucidate the imminent investment pockets.
• A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
• Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis of the key segments of the industry helps understand the applications and products of single cell multiomics used across the globe.
• Key market players and their strategies have been analyzed to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
• By Type
o Single Cell Genomics
o Single Cell Proteomics
o Single Cell Transcriptomics
o Single Cell Metabolomics
• By Application
o Oncology
o Cell Biology
o Neurology
o Others
• By Technique
o Single-Cell Isolation & Dispensing
o Oncology
o Cell Biology
o Neurology
o Others
o Single-Cell Analysis
o Oncology
o Cell Biology
o Neurology
o Others
• By End User
o Academic Institutes
o Contract Research Organizations
o Pharmaceutical & Biotech Companies
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
Bio-Rad Laboratories (Celsee, Inc.)
BGI Genomics Co. Ltd.
Cytiva life science (Previously GE)
Fluidigm Corporation
Illumina, Inc.
10x Genomics
NanoString Technologies
MissionBio
QIAGEN N.V.
Takara Bio
1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Technological advancements in single-cell analysis products
3.5.1.2.Increase in adoption of personalized medicine for the screening and diagnostics of genetic disorders
3.5.2.Restraints
3.5.2.1.High cost of single-cell analysis products
3.5.2.2.Dearth of skilled professionals
3.5.3.Opportunities
3.5.3.1.Increasing funding in the research of single cell multiomics
3.5.4.Impact analysis
3.6.Covid-19 Impact analysis on the single cell multiomics market
CHAPTER 4:SINGLE CELL MULTIOMICS MARKET, BY TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Single Cell Genomics
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Single Cell Proteomics
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.4.Single Cell Transcriptomics
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
4.5.Single Cell Metabolomics
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast
4.5.3.Market analysis, by country
CHAPTER 5:SINGLE CELL MULTIOMICS MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Oncology
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Cell Biology
5.3.1.Market size and forecast
5.3.2.Market analysis, by country
5.4.Neurology
5.4.1.Market size and forecast
5.4.2.Market analysis, by country
5.5.Others
5.5.1.Market size and forecast
5.5.2.Market analysis, by country
CHAPTER 6:SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE
6.1.Overview
6.1.1.Market size and forecast
6.2.Single-Cell Isolation and Dispensing
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.2.3.Market size and forecast, by application
6.2.3.1.Oncology
6.2.3.1.1.Market size and forecast
6.2.3.2.Cell Biology
6.2.3.2.1.Market size and forecast
6.2.3.3.Neurology
6.2.3.3.1.Market size and forecast
6.2.3.4.Others
6.2.3.4.1.Market size and forecast
6.3.Single-Cell Analysis
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.3.3.Market size and forecast, by application
6.3.3.1.Oncology
6.3.3.1.1.Market size and forecast
6.3.3.2.Cell Biology
6.3.3.2.1.Market size and forecast
6.3.3.3.Neurology
6.3.3.3.1.Market size and forecast
6.3.3.4.Others
6.3.3.4.1.Market size and forecast
CHAPTER 7:SINGLE CELL MULTIOMICS MARKET, BY END USER
7.1.Overview
7.1.1.Market size and forecast
7.2.Academic Institutes
7.2.1.Market size and forecast, by region
7.2.2.Market analysis, by country
7.3.Contract Research Organizations
7.3.1.Market size and forecast, by region
7.3.2.Market analysis, by country
7.4.Pharmaceutical and Biotech Companies
7.4.1.Market size and forecast, by region
7.4.2.Market analysis, by country
CHAPTER 8:SINGLE CELL MULTIOMICS MARKET, BY REGION
8.1.Overview
8.1.1.Market size and forecast
8.2.North America
8.2.1.Key market trends, growth factors, and opportunities
8.2.2.Market size and forecast, by country
8.2.2.1.U.S. Single cell multiomics market, by type
8.2.2.2.U.S. Single cell multiomics market, by application
8.2.2.3.U.S. Single cell multiomics market, by technique
8.2.2.4.U.S. Single cell multiomics market, by end user
8.2.2.5.Canada Single cell multiomics market, by type
8.2.2.6.Canada Single cell multiomics market, by application
8.2.2.7.Canada Single cell multiomics market, by application
8.2.2.8.Canada Single cell multiomics market, by end user
8.2.2.9.Mexico Single cell multiomics market, by type
8.2.2.10.Mexico Single cell multiomics market, by application
8.2.2.11.Mexico Single cell multiomics market, by application
8.2.2.12.Mexico Single cell multiomics market, by end user
8.2.3.North America market size and forecast, by type
8.2.4.North America market size and forecast, by application
8.2.5.North America market size and forecast, by technique
8.2.5.1.North America single-cell isolation and dispensing, by application
8.2.5.2.North America single-cell analysis, by application
8.2.6.North America market size and forecast, by end user
8.3.Europe
8.3.1.Key market trends, growth factors, and opportunities
8.3.2.Market size and forecast, by country
8.3.2.1.Germany Single cell multiomics market, by type
8.3.2.2.Germany Single cell multiomics market, by application
8.3.2.3.Germany Single cell multiomics market, by application
8.3.2.4.Germany Single cell multiomics market, by end user
8.3.2.5.France Single cell multiomics market, by type
8.3.2.6.France Single cell multiomics market, by application
8.3.2.7.France Single cell multiomics market, by technique
8.3.2.8.France Single cell multiomics market, by end user
8.3.2.9.UK Single cell multiomics market, by type
8.3.2.10.UK Single cell multiomics market, by application
8.3.2.11.UK Single cell multiomics market, by technique
8.3.2.12.UK Single cell multiomics market, by end user
8.3.2.13.Italy Single cell multiomics market, by type
8.3.2.14.Italy Single cell multiomics market, by application
8.3.2.15.Italy Single cell multiomics market, by technique
8.3.2.16.Italy Single cell multiomics market, by end user
8.3.2.17.Spain Single cell multiomics market, by type
8.3.2.18.Spain Single cell multiomics market, by application
8.3.2.19.Spain Single cell multiomics market, by technique
8.3.2.20.Spain Single cell multiomics market, by end user
8.3.2.21.Rest of Europe Single cell multiomics market, by type
8.3.2.22.Rest of Europe Single cell multiomics market, by application
8.3.2.23.Rest of Europe Single cell multiomics market, by technique
8.3.2.24.Rest of Europe Single cell multiomics market, by end user
8.3.3.Europe market size and forecast, by type
8.3.4.Europe market size and forecast, by application
8.3.5.Europe market size and forecast, by technique
8.3.5.1.Europe single-cell isolation and dispensing, by application
8.3.5.2.Europe single-cell analysis, by application
8.3.6.Europe market size and forecast, by end user
8.4.Asia-Pacific
8.4.1.Key market trends, growth factors, and opportunities
8.4.2.Market size and forecast, by country
8.4.2.1.Japan Single cell multiomics market, by type
8.4.2.2.Japan Single cell multiomics market, by application
8.4.2.3.Japan Single cell multiomics market, by technique
8.4.2.4.Japan Single cell multiomics market, by end user
8.4.2.5.China Single cell multiomics market, by type
8.4.2.6.China Single cell multiomics market, by application
8.4.2.7.China Single cell multiomics market, by technique
8.4.2.8.China Single cell multiomics market, by end user
8.4.2.9.Australia Single cell multiomics market, by type
8.4.2.10.Australia Single cell multiomics market, by application
8.4.2.11.Australia Single cell multiomics market, by technique
8.4.2.12.Australia Single cell multiomics market, by end user
8.4.2.13.India Single cell multiomics market, by type
8.4.2.14.India Single cell multiomics market, by application
8.4.2.15.India Single cell multiomics market, by technique
8.4.2.16.India Single cell multiomics market, by end user
8.4.2.17.South Korea Single cell multiomics market, by type
8.4.2.18.South Korea Single cell multiomics market, by application
8.4.2.19.South Korea Single cell multiomics market, by technique
8.4.2.20.South Korea Single cell multiomics market, by end user
8.4.2.21.Rest of Asia-Pacific Single cell multiomics market, by type
8.4.2.22.Rest of Asia-Pacific Single cell multiomics market, by application
8.4.2.23.Rest of Asia-Pacific Single cell multiomics market, by technique
8.4.2.24.Rest of Asia-Pacific Single cell multiomics market, by end user
8.4.3.Asia-Pacific market size and forecast, by type
8.4.4.Asia-Pacific market size and forecast, by application
8.4.5.Asia-Pacific market size and forecast, by technique
8.4.5.1.Asia-Pacific single-cell isolation and dispensing, by application
8.4.5.2.Asia-Pacific single-cell analysis, by application
8.4.6.Asia-Pacific market size and forecast, by end user
8.5.LAMEA
8.5.1.Key market trends, growth factors, and opportunities
8.5.2.Market size and forecast, by country
8.5.2.1.Brazil Single cell multiomics market, by type
8.5.2.2.Brazil Single cell multiomics market, by application
8.5.2.3.Brazil Single cell multiomics market, by technique
8.5.2.4.Brazil Single cell multiomics market, by end user
8.5.2.5.Saudi Arabia Single cell multiomics market, by type
8.5.2.6.Saudi Arabia Single cell multiomics market, by application
8.5.2.7.Saudi Arabia Single cell multiomics market, by technique
8.5.2.8.Saudi Arabia Single cell multiomics market, by end user
8.5.2.9.Rest of LAMEA Single cell multiomics market, by type
8.5.2.10.Rest of LAMEA Single cell multiomics market, by application
8.5.2.11.Rest of LAMEA Single cell multiomics market, by technique
8.5.2.12.Rest of LAMEA Single cell multiomics market, by end user
8.5.3.LAMEA market size and forecast, by type
8.5.4.LAMEA market size and forecast, by application
8.5.5.LAMEA market size and forecast, by technique
8.5.5.1.LAMEA single-cell isolation and dispensing, by application
8.5.5.2.LAMEA single-cell analysis, by application
8.5.6.LAMEA market size and forecast, by end user
CHAPTER 9:COMPANY PROFILES
9.1.BGI Genomics Co. Ltd.
9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance
9.1.6.Key strategic moves and developments
9.2.Bio-Rad Laboratories, Inc.
9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business performance
9.2.6.Key strategic moves and developments
9.3.Danaher Corporation (Cytiva Life sciences)
9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.3.5.Business performance
9.3.6.Key strategic moves and developments
9.4.Fluidigm Corporation
9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.4.5.Business performance
9.4.6.Key strategic moves and developments
9.5.Illimina Inc.
9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product portfolio
9.5.5.Business performance
9.6.Mission Bio, Inc.
9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.6.5.Key strategic moves and developments
9.7.NanoString Technologies, Inc
9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product portfolio
9.7.5.Business performance
9.7.6.Key strategic moves and developments
9.8.Qiagen N.V.
9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance
9.8.6.Key strategic moves and developments
9.9.Takara Holdings Inc. (Takara Bio Group)
9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio
9.9.5.Business performance
9.9.6.Key strategic moves and developments
9.10.10x Genomics, Inc.
9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
9.10.5.Business performance
9.10.6.Key strategic moves and developments
TABLE 01.GLOBAL SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 02.SINGLE CELL GENOMICS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 03.SINGLE CELL PROTEOMICS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 04.SINGLE CELL TRANSCRIPTOMICSMARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 05.SINGLE CELL METABOLOMICS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 06.GLOBAL SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 07.ONCOLOGY MARKET, BY REGION, 2020-2030($MILLION)
TABLE 08.CELL BIOLOGY MARKET, BY REGION, 2020-2030($MILLION)
TABLE 09.NEUROLOGY MARKET, BY REGION, 2020-2030($MILLION)
TABLE 10.OTHERS MARKET, BY REGION, 2020-2030($MILLION)
TABLE 11.GLOBAL SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030($MILLION)
TABLE 12.SINGLE-CELL ISOLATION AND DISPENSING MARKET, BY REGION, 2020-2030($MILLION)
TABLE 13.SINGLE-CELL ISOLATION AND DISPENSING, BY APPICATION, 2020–2030 ($MILLION)
TABLE 14.SINGLE-CELL ANALYSIS MARKET, BY REGION, 2020-2030($MILLION)
TABLE 15.SINGLE-CELL ANALYSIS, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 16.GLOBAL SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 17.ACADEMIC INSTITUTES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 18.CONTRACT RESEARCH ORGANIZATIONS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 19.PHARMACEUTICAL AND BIOTECH COMPANIES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 20.GLOBAL SINGLE CELL MULTIOMICS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 21.NORTH AMERICA SINGLE CELL MULTIOMICS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 22.U.S. SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 23.U.S. SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 24.U.S SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 25.U.S. SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 26.CANADA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 27.CANADA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 28.CANADA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 29.CANADA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 30.MEXICO SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 31.MEXICO SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 32.MEXICO SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 33.MEXICO SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 34.NORTH AMERICA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 35.NORTH AMERICA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 36.NORTH AMERICA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 37.NORTH AMERICA SINGLE-CELL ISOLATION AND DISPENSING, BY APPLICATION, 2020-2030
TABLE 38.NORTH AMERICA SINGLE-CELL ANALYSIS, BY APPLICATION, 2020-2030
TABLE 39.NORTH AMERICA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 40.EUROPE SINGLE CELL MULTIOMICS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 41.GERMANY SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 42.GERMANY SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 43.GERMANY SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 44.GERMANY SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 45.FRANCE SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 46.FRANCE SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 47.LAMEA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 48.FRANCE SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 49.UK SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 50.UK SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 51.UK SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 52.UK SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 53.ITALY SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 54.ITALY SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 55.ITALY SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 56.ITALY SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 57.SPAIN SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 58.SPAIN SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 59.LAMEA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 60.SPAIN SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 61.REST OF EUROPE SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 62.REST OF EUROPE SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 63.REST OF EUROPE SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 64.REST OF EUROPE SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 65.EUROPE SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 66.EUROPE SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 67.EUROPE SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 68.EUROPE SINGLE-CELL ISOLATION AND DISPENSING, BY APPLICATION, 2020-2030
TABLE 69.EUROPE SINGLE-CELL ANALYSIS, BY APPLICATION, 2020-2030
TABLE 70.EUROPE SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 71.ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 72.JAPAN SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 73.JAPAN SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 74.LAMEA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 75.JAPAN SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 76.CHINA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 77.CHINA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 78.LAMEA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 79.CHINA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 80.AUSTRALIA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 81.AUSTRALIA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 82.AUSTRALIA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 83.AUSTRALIA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 84.INDIA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 85.INDIA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 86.INDIA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 87.INDIA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 88.SOUTH KOREA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 89.SOUTH KOREA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 90.SOUTH KOREA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 91.SOUTH KOREA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 92.REST OF ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 93.REST OF ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 94.REST OF ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 95.REST OF ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 96.ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 97.ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 98.ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 99.ASIA-PACIFIC SINGLE-CELL ISOLATION AND DISPENSING, BY APPLICATION, 2020-2030
TABLE 100.ASIA-PACIFIC SINGLE-CELL ANALYSIS, BY APPLICATION, 2020-2030
TABLE 101.ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 102.LAMEA SINGLE CELL MULTIOMICS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 103.BRAZIL SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 104.BRAZIL SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 105.BRAZIL SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 106.BRAZIL SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 107.SAUDI ARABIA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 108.SAUDI ARABIA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 109.SAUDI ARABIA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 110.SAUDI ARABIA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 111.REST OF LAMEA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 112.REST OF LAMEA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 113.LAMEA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 114.REST OF LAMEA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 115.LAMEA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 116.LAMEA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 117.LAMEA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 118.LAMEA SINGLE-CELL ISOLATION AND DISPENSING, BY APPLICATION, 2020-2030
TABLE 119.LAMEA SINGLE-CELL ANALYSIS, BY APPLICATION, 2020-2030
TABLE 120.LAMEA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 121.BGI GENOMICS: COMPANY SNAPSHOT
TABLE 122.BGI GENOMICS: PRODUCT PORTFOLIO
TABLE 123.BGI GENOMICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 124.BIO-RAD: COMPANY SNAPSHOT
TABLE 125.BIO-RAD: OPERATING SEGMENTS
TABLE 126.BIO-RAD: PRODUCT PORTFOLIO
TABLE 127.BIO-RAD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 128.DANAHER: COMPANY SNAPSHOT
TABLE 129.DANAHER: OERATING SEGMENT
TABLE 130.DANAHER: PRODUCT PORTFOLIO
TABLE 131.DANAHER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 132.FLUIDIGM: COMPANY SNAPSHOT
TABLE 133.FLUIDIGM: OPERATING SEGMENTS
TABLE 134.FLUIDIGM: PRODUCT PORTFOLIO
TABLE 135.FLUIDIGM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 136.ILLUMINA: COMPANY SNAPSHOT
TABLE 137.ILLUMINA: OERATING SEGMENT
TABLE 138.ILLUMINA: PRODUCT PORTFOLIO
TABLE 139.MISSION BIO: COMPANY SNAPSHOT
TABLE 140.MISSION BIO: OPERATING SEGMENTS
TABLE 141.MISSION BIO: PRODUCT PORTFOLIO
TABLE 142.MISSION BIO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 143.NANOSTRING TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 144.NANOSTRING TECHNOLOGIES: OPERATING SEGMENTS
TABLE 145.NANOSTRING TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 146.NANOSTRING TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 147.QIAGEN: COMPANY SNAPSHOT
TABLE 148.QIAGEN: OERATING SEGMENT
TABLE 149.QIAGEN: PRODUCT PORTFOLIO
TABLE 150.QIAGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 151.TAKARA HOLDINGS: COMPANY SNAPSHOT
TABLE 152.TAKARA HOLDINGS: PRODUCT PORTFOLIO
TABLE 153.TAKARA HOLDINGS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 154.10X GENOMICS: COMPANY SNAPSHOT
TABLE 155.10X GENOMICS: OERATING SEGMENT
TABLE 156.10X GENOMICS.: PRODUCT PORTFOLIO
TABLE 157.10X GENOMICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
